A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Clinical trial NCT06858579 · RECRUITING
Trial details
- NCT number
- NCT06858579
- Sponsor
- Dianthus Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2028-12-31
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.